Agilon Health Inc [AGL] stock prices are down -0.95% to $2.09 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AGL shares have gain 17.42% over the last week, with a monthly amount drifted -15.04%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Agilon Health Inc [NYSE: AGL] stock has seen the most recent analyst activity on November 11, 2024, when JMP Securities downgraded its rating to a Mkt Perform. Previously, William Blair downgraded its rating to Mkt Perform on November 08, 2024. On October 30, 2024, downgrade downgraded it’s rating to Sell and revised its price target to $2.50 on the stock. BofA Securities downgraded its rating to a Underperform but stick to its price target of $3 on October 02, 2024. Robert W. Baird initiated its recommendation with a Neutral and recommended $6 as its price target on May 30, 2024. Citigroup started tracking with a Neutral rating for this stock on April 22, 2024, and assigned it a price target of $6. In a note dated March 06, 2024, Barclays initiated an Underweight rating and provided a target price of $5 on this stock.
The stock price of Agilon Health Inc [AGL] has been fluctuating between $1.50 and $13.76 over the past year. Currently, Wall Street analysts expect the stock to reach $4.4 within the next 12 months. Agilon Health Inc [NYSE: AGL] shares were valued at $2.09 at the most recent close of the market. An investor can expect a potential return of 110.53% based on the average AGL price forecast.
Analyzing the AGL fundamentals
The Agilon Health Inc [NYSE:AGL] reported sales of 5.59B for trailing twelve months, representing a surge of 19.35%. Gross Profit Margin for this corporation currently stands at -0.01% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.06%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.5 and Total Capital is -0.51. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.05 points at the first support level, and at 2.01 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.17, and for the 2nd resistance point, it is at 2.25.
Ratios To Look Out For
It’s worth pointing out that Agilon Health Inc [NYSE:AGL]’s Current Ratio is 1.29. In addition, the Quick Ratio stands at 1.29 and the Cash Ratio stands at 0.11. Considering the valuation of this stock, the price to sales ratio is 0.15, the price to book ratio is 1.50.
Transactions by insiders
Recent insider trading involved Sell Steven, CEO & President, that happened on Sep 12 ’24 when 20000.0 shares were purchased.
